The Flamenco Clinical Movement Analysis System allows capturing movement with up to 4 video cameras, perfectly synchronized with a ground reaction force vector and up to 16 channels of EMG. The system was developed in close collaboration with several clinical gait analysis labs. It is an effective tool for clinical decision making in a wide range of pathologies, including cerebral palsy and stroke. The Flamenco system enables physiotherapists and other rehabilitation professionals to assess a patient’s gait in less than one hour, without the need for an engineer to run the system.
Read more

Nova Biomedical’s StatStrip Glucose Hospital Meter System now offers bidirectional wireless connectivity to the hospital’s HIS or LIS with complete security to protect patient data. The wireless connectivity can transmit patient results directly from the patient bedside, alleviating the need to bring the meter to a fixed location for meter docking and data transmission. Wireless connectivity saves time for the caregiver and allows for faster charting of results and clinical decision making to improve patient care. StatStrip Glucose’s dual-band wireless connectivity provides complete security and encryption to ensure that patient data remains uncompromised. Nova now offers a full range of StatStrip Glucose wireless connectivity capabilities, including wireless meters, wireless carrying cases, and wireless docking stations. All of the wireless devices use industry standard POCT1-A2 data format and are compatible with a choice of middleware partners. StatStrip Glucose is the only glucose meter cleared by the U.S. Food and Drug Administration (FDA) for use with all patients, in all healthcare settings, including critical care. The device received this clearance in 2014 after an extensive, nearly four-year study conducted at five major university medical centres, which included 1,698 critically ill patients with over 257 clinical conditions. Over 8,000 medications were investigated for potential interference to StatStrip Glucose measurement. The device demonstrated excellent agreement compared to central laboratory reference methods and no clinical interferences were found. In addition to the study submitted to the FDA, 138 other independent studies over the last eight years
Read more

MyDiagnostick is a new diagnostic device (MDD IIa) for the detection and diagnosis of AF. It generates a Lead I ECG which is automatically analysed for the presence of AF. MyDiagnostick is very easy to use, with no buttons to control or parameters to be set. When holding the handles (electrodes) it will automatically switch on and start the ECG recording. After only one minute, the AF outcome is displayed by MyDiagnostick turning either red: AF detected, or green: no AF detected. After use, the device will switch off automatically. It is able to record and store over 140 ECGs and thousands of measuring results. ECGs and results can be displayed and printed whenever MyDiagnostick is connected to a PC or a laptop by the USB cable provided. The current Holter- and event recorders use ECG skin electrodes and need careful setting, thus requiring medical personnel. Furthermore these systems do not have embedded AF detection algorithms, which means that AF episodes can only be determined afterwards. The device does not depend on any infrastructure to diagnose AF and therefore can be used anywhere, anytime, also at the patient’s home or at work. MyDiagnostick has a clinically proven sensitivity of 100% and specificity of 95.7%, which allows also the early detection of paroxysmal AF.
Read more

The recently introduced Proxima in-line patient-dedicated arterial blood gas analyser offers the benefits of receiving blood gas results, just like blood pressure, within the patient’s bed space. The Proxima system represents the next step in blood gas point-of-care testing (POCT) as it is attached directly to the patient through their arterial line, in-series with the blood pressure transducer.  Without leaving the bedside, closed blood samples can be withdrawn frequently, analysed and then returned directly to the patient.  This enables rapid delivery of blood gas results to aid early decision making and closer control of therapy for critically ill patients, whilst also conserving blood and reducing nurse dependency
Read more

Progetti is introducing its first generation high-level ultrasound products, which will be officially launched by June 2015. Based on a revolutionary platform and latest imaging technology, the Progetti ultrasound series elevates the image performance to major brands in the market, satisfying the demand of clinicians and giving them the necessary confidence to make their clinical decision and grow the excellence in patient care, thanks to the innovative imaging capabilities. Progetti’s ultrasound series is engineered to meet today’s most demanding needs, from deep abdominal, vascular to superficial small parts. It is designed to make abdominal, ob/gyn, cardiac, intraoperative vascular and musculoskeletal image quality detection. These are some of the main performances offered in our ultrasound devices series: Adaptive Colour Doppler, Pulse and Continuous Wave Doppler, Tissue Doppler Imaging (TDI), Intima-Media Thickness (IMT), Real-time 3D and 4D acquisition, spatial compound imaging, pulse inversion harmonic imaging.
Read more